Impact of Adapted Physical Activity and Diet Counselling on Health-related Quality of Life in Women Undergoing Adjuvant Breast Cancer Therapy

Overview

Journal Sci Rep

Specialty Science

Date 2025 Mar 11

PMID 40064980

Authors

Celia Touraine

William Jacot

Sophie Gourgou

Marion Carayol

Pierre Senesse

Gregory Ninot

Caroline Mollevi

Affiliations

Soon will be listed here.

Abstract

In the monocentric APAD1 trial, 143 women with non-metastatic breast cancer were randomised to undergo either an adapted physical activity and diet counselling (APAD) program or usual care. Health-related quality of life (HRQoL) was prospectively evaluated using the EORTC QLQ-C30 questionnaire at baseline, during treatment (adjuvant chemotherapy and radiotherapy) and during follow-up. Our objective was two-fold: to analyse the impact of APAD on HRQoL using three approaches; to illustrate the advantages and disadvantages of each approach, and derive methodological recommendations. Analytical approaches utilised were: statistical testing to compare the mean HRQoL scores between baseline and end of study in both groups and the mean HRQoL scores between the two groups at the different assessment times; linear mixed models that modelled the longitudinal score data in both groups and tested whether the score trajectories were different between the groups; a survival analysis comparing the time to deterioration of HRQoL between the groups using a minimal clinically important difference. This study shows a substantial clinical benefit of the APAD intervention on HRQoL, especially for global health status/HRQoL, functioning scales and the fatigue symptom scale. Furthermore, this study highlights the advantages and disadvantages of three standard approaches used to analyse HRQoL data.Trial registration: The APAD1 study was registered with ClinicalTrials.gov (number NCT01495650, date 20/12/2011).

References

Winter A, Cuer B, Conroy T, Juzyna B, Gourgou S, Mollevi C . Flexible modeling of longitudinal health-related quality of life data accounting for informative dropout in a cancer clinical trial. Qual Life Res. 2022; 32(3):669-679. DOI: 10.1007/s11136-022-03252-6. View

Bascoul-Mollevi C, Barbieri A, Bourgier C, Conroy T, Chauffert B, Hebbar M . Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results. Qual Life Res. 2020; 30(1):91-103. DOI: 10.1007/s11136-020-02605-3. View

Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5):365-76. DOI: 10.1093/jnci/85.5.365. View

Hagen K, Aas T, Kvaloy J, Eriksen H, Soiland H, Lind R . Fatigue, anxiety and depression overrule the role of oncological treatment in predicting self-reported health complaints in women with breast cancer compared to healthy controls. Breast. 2016; 28:100-6. DOI: 10.1016/j.breast.2016.05.005. View

de Boer M, Waterlander W, Kuijper L, Steenhuis I, Twisk J . Testing for baseline differences in randomized controlled trials: an unhealthy research behavior that is hard to eradicate. Int J Behav Nutr Phys Act. 2015; 12:4. PMC: 4310023. DOI: 10.1186/s12966-015-0162-z. View

Osoba D, Rodrigues G, Myles J, Zee B, Pater J . Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998; 16(1):139-44. DOI: 10.1200/JCO.1998.16.1.139. View

Coens C, Pe M, Dueck A, Sloan J, Basch E, Calvert M . International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. Lancet Oncol. 2020; 21(2):e83-e96. DOI: 10.1016/S1470-2045(19)30790-9. View

Carayol M, Romieu G, Bleuse J, Senesse P, Gourgou-Bourgade S, Sari C . Adapted physical activity and diet (APAD) during adjuvant breast cancer therapy: design and implementation of a prospective randomized controlled trial. Contemp Clin Trials. 2013; 36(2):531-43. DOI: 10.1016/j.cct.2013.09.016. View

VAN Vulpen J, Peeters P, Velthuis M, van der Wall E, May A . Effects of physical exercise during adjuvant breast cancer treatment on physical and psychosocial dimensions of cancer-related fatigue: A meta-analysis. Maturitas. 2016; 85:104-11. DOI: 10.1016/j.maturitas.2015.12.007. View

10.

Jaeschke R, Singer J, Guyatt G . Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989; 10(4):407-15. DOI: 10.1016/0197-2456(89)90005-6. View

11.

Bonnetain F, Dahan L, Maillard E, Ychou M, Mitry E, Hammel P . Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma. Eur J Cancer. 2010; 46(15):2753-62. DOI: 10.1016/j.ejca.2010.07.023. View

12.

Carayol M, Ninot G, Senesse P, Bleuse J, Gourgou S, Sancho-Garnier H . Short- and long-term impact of adapted physical activity and diet counseling during adjuvant breast cancer therapy: the "APAD1" randomized controlled trial. BMC Cancer. 2019; 19(1):737. PMC: 6659309. DOI: 10.1186/s12885-019-5896-6. View

13.

Gupta D, Lis C, Grutsch J . The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manage. 2007; 34(1):40-7. DOI: 10.1016/j.jpainsymman.2006.10.012. View

14.

Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S . Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer. 2003; 98(9):1786-801. DOI: 10.1002/cncr.11742. View

15.

Branstrom R, Petersson L, Saboonchi F, Wennman-Larsen A, Alexanderson K . Physical activity following a breast cancer diagnosis: Implications for self-rated health and cancer-related symptoms. Eur J Oncol Nurs. 2015; 19(6):680-5. DOI: 10.1016/j.ejon.2015.04.008. View

16.

Canario A, Cabral P, de Paiva L, Florencio G, Spyrides M, da Silveira Goncalves A . Physical activity, fatigue and quality of life in breast cancer patients. Rev Assoc Med Bras (1992). 2016; 62(1):38-44. DOI: 10.1590/1806-9282.62.01.38. View

17.

Bardwell W, Ancoli-Israel S . Breast Cancer and Fatigue. Sleep Med Clin. 2008; 3(1):61-71. PMC: 2390812. DOI: 10.1016/j.jsmc.2007.10.011. View

18.

Bascoul-Mollevi C, Savina M, Anota A, Barbieri A, Azria D, Bonnetain F . Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTD. Comput Methods Programs Biomed. 2018; 158:153-159. DOI: 10.1016/j.cmpb.2018.02.010. View

19.

Hamidou Z, Dabakuyo T, Mercier M, Fraisse J, Causeret S, Tixier H . Time to deterioration in quality of life score as a modality of longitudinal analysis in patients with breast cancer. Oncologist. 2011; 16(10):1458-68. PMC: 3228064. DOI: 10.1634/theoncologist.2011-0085. View

20.

Anota A, Hamidou Z, Paget-Bailly S, Chibaudel B, Bascoul-Mollevi C, Auquier P . Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?. Qual Life Res. 2013; 24(1):5-18. PMC: 4282717. DOI: 10.1007/s11136-013-0583-6. View